CLISEQ
Hematology Diagnostics
StartupCLISEQ is a Bnei Brak-based startup in the Health Tech & Life Sciences sector, established in 2023. Hematology Diagnostics. The company has 1-10 employees. Core technologies: Biologicals, Cells.
The company follows a B2B business model. Product stage: R&D.
- StagePre-Seed
- ProductR&D
- ModelB2B
- Employees1-10
- HQBnei Brak
- DistrictCenter District
- Last RoundUndisclosed
1 article covered by sources including investors.10xgenomics.com.
What does CLISEQ do?
CLISEQ Ltd. is a translational diagnostics company spun out of the Weizmann Institute of Science, via its commercialization arm Yeda Research and Development Company Ltd., that is advancing minimally invasive diagnostic approaches for hematologic disorders. The company holds exclusive rights to a patented technology developed at the Weizmann Institute, which enables use of peripheral blood single-cell RNA sequencing (scRNA-seq) to detect conditions such as myelodysplastic syndromes (MDS) as an alternative to bone-marrow aspiration. In partnership with 10x Genomics, Inc. and the Weizmann Institute, CLISEQ is conducting an international multi-site clinical trial (PERIBLOOD) enrolling over 1,500 participants across several continents to validate the technology’s clinical utility and facilitate future diagnostics workflows in hematology.
What sector is CLISEQ in?
CLISEQ operates in Health Tech & Life Sciences, Digital Healthcare, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Life Sciences.
Where is CLISEQ located?
CLISEQ is based in Kibuts Galuyot St 89, Bnei Brak, Israel, Center District.